Abstract 547: Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeutics
Samantha O'Hara, Ryan Larson(CTI BioPharma (United States)), Michèle J. Hoffmann(University Hospital of Bern), Chris Garbe, Byoung Y. Ryu(CTI BioPharma (United States)), Laurie Beitz(Seattle Children's Hospital), Andrew M. Scharenberg(CTI BioPharma (Italy)), Ryan Koning, David Vereide, Ashley Yingst, Kristen Mittelsteadt(University of Washington), Teisha J. Rowland, Kathryn Michels(CTI BioPharma (United States)), Seungjin Shin(Vector (United States)), Ryan Crisman, Chris Nicolai, Mark Pankau(CTI BioPharma (Italy))
Cited by 0
Related Papers
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology
|Nature|2001|897